Literature DB >> 22706195

Pneumococcal disease: emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital.

Enrique Chacon-Cruz1, Yazbeck Velazco-Mendez, Samuel Navarro-Alvarez, Rosa M Rivas-Landeros, Maria Luisa Volker, Graciano Lopez-Espinoza.   

Abstract

INTRODUCTION: Mexico was the country to initiate massive vaccination with heptavalent pneumococcal conjugate vaccine (PCV-7) in children. There is no information regarding pneumococcal invasive disease (PID) in children before and after implementation of PCV-7 in Mexico or elsewhere in Latin America.
METHODOLOGY: During October 2005 to September 2010, active surveillance for pediatric PID was initiated at Tijuana General Hospital. Only culture-confirmed cases from sterile fluids were included in the study. Serotype identification was also performed.
RESULTS: Twenty-eight pediatric PID cases were confirmed. Streptococcus pneumoniae was the main cause of pleural empyema (n = 13). It was also the second most common cause of confirmed bacterial meningitis (n = 10), followed by Neisseria meningitidis (n = ?), and the only cause of otomastoiditis with bacterial isolation (n = 5). Vaccine-associated serotypes decreased from 54% before PCV-7 introduction to the vaccination schedule, to only 5.6% after PCV-7 implementation. Serotypes 19A and 7F (47% and 33% respectively were predominant following PCV-7 vaccination.
CONCLUSIONS: Serotype substitution in PID is present in the northern border of Mexico following PCV-7 vaccination in children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706195     DOI: 10.3855/jidc.1954

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  3 in total

1.  Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital.

Authors:  Enrigue Chacon-Cruz; R M Rivas-Landeros; M L Volker-Soberanes
Journal:  Ther Adv Vaccines       Date:  2014-11

Review 2.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.

Authors:  M A Fletcher; H-J Schmitt; M Syrochkina; G Sylvester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-23       Impact factor: 3.267

3.  Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile.

Authors:  Alberto Fica; Nicolás Bunster; Felipe Aliaga; Felipe Olivares; Lorena Porte; Stephanie Braun; Jeannette Dabanch; Juan Carlos Hormázabal; Antonio Hernández; María Guacolda Benavides
Journal:  Braz J Infect Dis       Date:  2013-10-10       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.